Digg
Del.icio.us
Yahoo
Technorati
Googlize this
Blinklist
Facebook
Wikio
Meneame
1 National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/.
2 Dy G, Bekele L, Hanson L et al. Complementary and Alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004; 22: 4810-15
3 Eisenberg D. Perceptions about complementary therapies relative to conventional therapies about adults who use both: Results from a national survey. Ann Intern Med 2001; 135: 344-51
4 National Cancer Institute. Office of complementary and Alternative Medicine. http//www.cancer.gov/occam/information.html
5 Oh W, Kantoff P, Weinberg V et al. Multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylestilbestrol in patients with androgen-independent prostate cancer. J Clin Oncol 2004; 22:3705-12
6 Sparreboom A. Herbal remedies in United States: Potential interactions with anticancer agents. J Clin Oncol 2004; 22:2489-2503
7 Swisher EM, Cohn DE, Goff BA, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gyn Oncol 2002;84:363. PubMed
8 Friedman T, Slayton WB, Allen LS, et al. Use of alternative therapies for children with cancer. Pediatrics 1997;100(6):E1(2–6).
9 Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18(13):2505.
10 Jonas WB. Alternative medicine—learning from the past, examining the present, advancing to the future. JAMA 1998;280:1616.
11 Winslow LC, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002;162(10):1176.
12 Kroll DJ. Concerns and needs for research in herbal supplement pharmacotherapy and safety. J Herb Pharmacother 2001;1(2):3.
13 Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137(11):889.
14 Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997;127:61.
15 Deng G et al. Evidence-Based Clinical Practice Guidelines for Integrative
Oncology: Complementary Therapies and Botanicals Journal of the Society for Integrative Oncology, Summer 2009, Volume 7, Number 3
16 Encuesta sobre el uso de Medicina Complementaria en pacientes oncológicos. P. Lianes, J Remon et al, primer Congreso SEOM 2010.
17 Eisenberg DM, Davis RB, Ettner Sl et al. Trends in alternative medicine in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575
18 Molassiotis et al. Use of complemenary and alternative medicine in cancer patients: a European survey. Annals of Oncology. 2005; 16: 665-663.
19 Milgrom LR. Vitalism, complexity and the concept of spin. Homeopathy. 2002;91(1):26-31.
20 Linde K, Hondras M, Vickers A, et al. Systematic reviews of complementary therapies--an annotated bibliography. Part 3: homeopathy. BMC Complementary and Alternative Medicine. 2001;1(1):4.
21 Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004845.
22 Thompson EA. Reilly D. The homeopathic approach to symptom control in the cancer patient: A prospective observational study.. Palliat Med 2002; 16: 227-233.
23 Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Annals of Internal Medicine. 2003;138(5):393-399.
24 Johnstone P. Complementary and Alternative Medicine:nonpharmacological interventions. Educational booklet. American Society of Clinical Oncology.2006.
25 Ezzo et al. Acupuncture-point stimulation for chemotherapy-induced vomiting and nausea. Journal of Clinical Oncology.2005;23:7188-7198.
26 Blom et al.Long-term follow-up of patients treated with acupuncture for xerostomia.Oral Disease.2000;6:15-24.
27 Blom et al. Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncology European Journal of Cancer.1996; 32B:182-190.
28 Wong et al. A phase II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics. 2003;54:472-480.
29 Johnstone et al. Acupuncture for xerostomia: clinical update.Cancer.2002;94:1151-1156.
30 Alimi et al.Analgesic effects of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. Journal of Clincial Oncology.2003:21:4120-4126.
31 Vickers et al. Acupuncture for postchemoterapy fatigue.A phase II study. Journal of Clinical Oncology.2004;22:1731-1735.
32 Johnstone et al. Acupuncture fot hot flashes secondary to cancer therapy: results of treating the eastern diagnosis of kidney water exhaust. Medical Acupuncture.2003;15:23-25.
33 Spence et al. Acupuncture increase nocturnal melatonin secretions and reduces insomnia and anxiety: a preliminary report. Journal of Neuropsichiatry Clinical Neuroscience.2004;16:19-28.
34 Vickers et al. Acupuncture for disnea in advanced cancer: a randomized, placebo-controlled pilot trial. BMC Palliative Cancer.2205;18:4-5.
35De Vita VT, Hellman S, Rosenberg SA. CAncer Principles and Practice of Oncology 7th edition. Editorial Lippincort. USA 2005.
36 Acupuntura y digitopuntura en el tratamiento de náuseas y vómitos asociados con la quimioterapia. Basado en los textos disponibles de www.cam-cancer.org. Adaptado por Esther Mahillo. Revista Geysalus, Junio 2006
37 Filshie J, Penn K, Ashley S, Davis CL. Acupuncture for the relief of cancer-related breathlessness. Palliat.Med 1996;10(2):145-50.
38 Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies(1). Int.J Radiat.Oncol.Biol Phys. 2001;50(2):353-7.
39 Hammar M, Frisk J, Grimas O, Hook M, Spetz AC, Wyon Y. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol. 1999;161(3):853-6.
40 Bhatt AD.Clinical Research on Ayurvedic therapies: myths, realities and challenges Journal of the Associated Physicians of India. 2001;49:558-562.
41 Centers for Disease Control and Prevention. Lead poisoning associated with Ayurvedic medicacions—five states, 2000-2003. Morbidity and Mortality Weekly Report. 2004;53(26):582-584.
42 Courson WA. State licensure and ayurvedic practice: planning for the future, managing the present. Newsletter of the National Ayurvedic Medical Association [online journal]. Autumn 2003. Accessed on February 22, 2005.
43 Kamila W et al. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bbr-Abl-Expressing cells. Molecular Cancer Research.2006;4(7):457-469
44 Centers for Disease Control and Prevention. Agency for Toxic Substances and Disease Registry. Lead Toxicity: Physiologic Effects. Agency for toxic substances and disease registry web. Accessed on September 1, 2005.
45 Chopra A, Doiphode VV. Ayurvedic medicine—core concept, therapeutic principles, and current relevance. Medical Clinics of North America. 2002;86(1):75-88.
46 JL Berdonces. Manual de Medicina Naturista. Editorial Oceano Ambar.2003
47Jordi Cebrián. Diccionario de Plantas Medicinales. RBA Libros 2002.
48 National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/.
49 Agency for Healthcare Research and Quality. Effect of the Supplemental Use of Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cancer. Evidence Report/Technology Assessment no. 75. Rockville, MD: Agency for Healthcare Research and Quality; 2003. AHRQ Publication Number 04-E002.
50 Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91(4):317. PubMed
51 Pantuck A et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clinical cancer Research. 2006; 12(13): 4018-4026.
52 Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res 1979; 39: 663–681.
53 Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301: 687–690.
54 Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 1985; 312: 137–141.
55 Padayatty SJ, Levine M. New insights into the physiology and pharmacology of vitamin C. CMAJ 2001; 164: 353–355.
56 Seifried HE, McDonald SS, Anderson DE, et al. The antioxidant conundrum in cancer. Cancer Res 2003;63:4295.
57 Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002;137(11):889.
58 Giles JT, Palat CT III, Chien SH, et al. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 2000;20(6):690-697.
59 Melchart D, Linde K, Fischer P, et al. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2003;(3):CD000530. Accessed at www.cochrane.org on August 1, 2006.
60 Melchart D, Linde K, Fischer P, et al. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2003;(3):CD000530. Accessed at www.cochrane.org on August 1, 2006.
61 Marshall I. Zinc for the common cold. Cochrane Database of Systematic Reviews. 2004;(3):CD001364. Accessed at www.cochrane.org on October 1, 2004.
62 Audera C, Patulny RV, Sander BH, et al. Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial. Medical Journal of Australia. 2001;175(7):359-362.
63 Coulehan JL, Eberhard S, Kapner L, et al. Vitamin C and acute illness in Navajo school children. New England Journal of Medicine. 1976;295(18):973-977.
64 Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2004;(3):CD000980. Accessed at www.cochrane.org on October 1, 2004.
65 Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res 1979; 39: 663–681.
66 Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301: 687–690.
67 Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 1985; 312: 137–141.
68 Mistletoe for cancer? A systematic review of randomised clinical trials.
Ernst E, Schmidt K, Steuer-Vogt MK. Internat J Cancer 2003; 107: 262-7.
69 Horneber M, Bueschel G, Huber R, et al. Mistletoe therapy in oncology. Cochrane Database of Systematic Reviews. 2008;(2):CD003297.
70 National Cancer Institute. Tea and Cancer Prevention. National Cancer Institute Web site. Accessed at www.cancer.gov/newscenter/pressreleases/tea on June 3, 2010.
71 Cochrane Database Syst Rev. 2009 Apr 15; (2):CD004845. Homeopathic medicines for adverse effects of cancer treatments.
72 Evidence-based complementary oncology: innovative approaches to optimise standard therapy strategies. Anticancer Res. 2010 May;30(5):1767-71.
73 Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Review Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008 Apr 16; (2):CD003297. Epub 2008 Apr 16.
74 Kienle GS, Kiene H. Eur Review Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. J Med Res. 2007 Mar 26; 12(3):103-19. 45-7.
75 Ferreira IC, Vaz JA, Vasconcelos MH, Martins A.Compounds from wild mushrooms with antitumor potencial. Anticancer Agents Med Chem. 2010 Jun 1;10(5):424-36. Review
76 Ulbricht C, Weissner W, Basch E, Giese N, Hammerness P, Rusie-Seamon E, Varghese M, Woods J. Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration. J Soc Integrative Oncology 2009; 7(2):66-72.Massachusetts General Hospital, Boston, MA, USA. Esta dirección electrónica esta protegida contra spam bots. Necesita activar JavaScript para visualizarla
77 Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1987;35(1):262.
78 Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Alt Med Rev 2002;7(3):236.
79 Bruce J et al. Meta-analysis of soy intake and breast cancer risk. Journal of National Cancer Institute. 2006 (vol 98): 459-471.
80 Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol 2000;18(5):1068.
81 Sattilaro A. Recalled by Life. 1982.
82 Carter JP, Saxe GP, Newbold V, Peres CE, Campeau RJ, Bernal-Green L. Hypothesis: Dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. Journal of the American College of Nutrition 1993;12(3):209-26.
83 American Cancer Society. Unproven methods of cancer management--macrobiotic diets for the treatment of cancer. CA A Cancer Journal for Clinicians 1989;39(4):248-51.
84 Newbold V. Remission of advanced malignant disease: A review of cases with a possible dietary factor. Cancer-Free: 30 Who Triumphed Over Cancer Naturally.Japan Publication, Inc., 1995:235-55.
85 McCallum PD & Polisena CG, eds. Clinical Guide to Oncology Nutrition; Chapter 16 by Molseed L. Alternative Therapies in Oncology; Chicago, Illinois: The American Dietetic Assn., 2000.
86 Lerner M. Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer. Cambridge, MA: MIT Press, 1994.
87 Helmich P. A triumph over cancer. Alternative Medicine 2004 Sep;61-4.
88 Helmich P. A triumph over cancer. Alternative Medicine 2004 Sep;61-4.
89 Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003;91:608.
90 Vinceti M, Malagoli C, Bergomi M, et al. Correspondence re: Duffield-Lillico et al., Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2003;12:77.
91 Combs GF. Status of selenium in prostate cancer prevention. Br J Cancer 2004;91:195.
92 Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003;95:1477.
93 Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002;11(7):630.
94 Dong Y, Zhang H, Hawthorn L, et al. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 2003;63(1):52.
95 Dong Y, Lee SO, Zhang H, et al. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res 2004;64(1):19.
96 Stratton MS, Reid ME, Schwartzberg G, et al. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs 2003;14(8):595.
97 Brem H, Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 1975;141(2):427.
98 Langer R, Brem H, Falterman K, et al. Isolations of a cartilage factor that inhibits tumor neovascularization. Science 1976;193(4247):70.
99 Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16(11):3649.
100 Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16(11):3649.
101 Batist G, Patenaude F, Champagne P, et al. Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels. Ann Oncol 2002;13(8):1259.
102 Milligan M, Fanning M, Hunter S, Tadjali M, Stevens E. Reflexology audit: patient satisfaction, impact on quality of life and availability in Scottish hospices. Int J Palliat Nurs 2002 Oct; 8(10):489-96.
103 Soden K, Vincent K, Craske S, Lucas C, Ashley S. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004 Mar; 18(2):87-92.
104 Wilkie DJ, Kampbell J, Cutshall S, Halabisky H, Harmon H, Johnson LP, et al. Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: a pilot study of a randomized clinical trial conducted within hospice care delivery. Hospice Journal - Physical, Psychosocial, & Pastoral Care of the Dying. 2000;15(3):31-53.
105 Fellows D et al. Aromatherapy and massage for symptoms relief in patients with cancer (review). The Cochrane database of Systemartic Reviews 2004, Issue 3.
106 Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage -- a randomized study. Acta Oncologica 2000;39(3):399-405.
107 Roy L. Massage therapy for people with cancer: a practitioner's experience. Positive Health. 2004 Feb;(96):48-50.
108 Knols et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomised and controlled clinical trials. Journal of Clinical Oncology.2005 Jun 1: 23(16): 3830-42
109 Hintz KJ, Yount GL, Kadar I, et al. Bioenergy definitions and research guidelines. Alternative Therapies in Health and Medicine. 2003;9(suppl 3):A13-A30.
110 Giasson M, Bouchard L. Effect of therapeutic touch on the well-being of persons with terminal cancer. Journal of Holistic Nursing. 1998 Sep;16(3):383-98.
111 Samarel N, Fawcett J, Davis MM, Ryan FM. Effects of dialogue and therapeutic touch on preoperative and postoperative experiences of breast cancer surgery: an exploratory study. Oncology Nursing Forum. 1998 Sep;25(8):1369-76.
112 Mustian KM, Katula JA, Gill DL, Roscoe JA, Lang D, Murphy K. Tai Chi Chuan, health-related quality of life and self-esteem: a randomized trial with breast cancer survivors. Support Care Cancer 2004, Dec 12(12):871-876.
113 Galantino ML, Capito L, Kane RJ, Ottey N, Switzer S, Packel L. The effects of Tai Chi and walking on fatigue and body mass index in women living with breast cancer: a pilot study. Rehabilitation Oncology. 2003 21(1):17-22.
114 Smith MC, Reeder F, Daniel L, Baramee J, Hagman J. Outcomes of touch therapies during bone marrow transplant. Alternative Therapies in Health & Medicine 2003 Jan-Feb;9(1):40-9.
115 Vicent S, Thompson JH. The effects of music upon the human blood pressure. Lancet. 1929;213(5506):534-538.
116 Magill RM. Role of Music therapy in integrative oncology.Journal of the Society of Integrative Oncology 2006;4: 79-81.
118 Mundy EA et al. The efficacy of behavioural intervention for cancer treatment-relates side effects. Seminars in clinical Neuropsychiatry. 2003; 8(4):253-275
119 Irwin MR et al. Effects of behavioural intervention, Tai chi, on varicella-zooster virus specific immunity and health functioning in older adults. Psycosomatic Medicine. 2003; 65(5):824-830.
120 Kiecolt-Glaser JK et al. Hypnosis as a modulator of cellular immune dysregulation during acute stress. Journal of Consulting and Clinical Psychology. 2001; 69(4): 674-682.
121 Wolsko PM, Eisenberg DM, Davis RB, et al. Use of mind-body medical therapies. Journal of General Internal Medicine. 2004;19(1):43-50.
122 Cannon WB. The Wisdom of the Body. New York, NY: Norton; 1932.
123 Selye H. The Stress of Life. New York, NY: McGraw-Hill; 1956.
124 Mundy EA, DuHamel KN, Montgomery GH. The efficacy of behavioral interventions for cancer treatment-related side effects. Seminars in Clinical Neuropsychiatry. 2003;8(4):253-275.
125 Lazar SW et al. Functional brain mapping of the relaxation response and meditation. Neuroreport. 2001; 26(4):411-420.
126 Davidson RJ et al. Alterations in brain immune function produced by mindfulness meditation. Neuroreport. 2000; 11(7):1581-1585.
127 Karen M Mustian. YOCAS. Yoga Significantly improves sleep, fatigue and quality of life in 410 cancer survivors: a URCC CCOP Research base RCT. ASCO Annual Meeting 2010-11-08
128 Gellert GA, Maxwell RM, Siegel BS. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: a 10-year follow-up study. J Clin Oncol 1993; 11: 66–69.
129 Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888–891.
130 Cunningham AJ, Edmonds CV, Jenkins GP, et al. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 1998; 7: 508–517.
131 Kraemer H, Spiegel D. Cunning but careless: analysis of a non-replication. Psychooncology 1999; 8: 273–275.
132 Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345: 1719–1726.
133 Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 2003;21(5):927.
134 Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 2003;21(1):129.
135 Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52(10):1479.
136 Strasser F et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer related anorexia-caquexia syndrome: A multicenter, phase II, randomised, Double-Bind, Placebo-controlled clinical trial from the cannabis-in-cachexia-study-group. Journal of Clinical Oncology. 2006; 24(21): 3394-3400.
137 Pace J, Conlin DS. Oral ingestion of encapsulated ginger and reported self-care actions for the relief of chemotherapy-associated nausea and vomiting. Dissertation Abstracts Int 1987;47(8):3297-B
138 Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000;84(3):367.
139 Dundee JW, Ghaly RG, Fitzpatrick KT, et al. Acupuncture prophylaxis of cancer chemotherapy-induced sickness. J R Soc Med 1989;82:268.
140 Williams CJ, Price H, Serious K. A randomized trial of acupressure for chemotherapy induced emesis. Proc Annu Meet Am Soc Clin Oncol 1992;1394(abst).
141 Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet 2003;361(9352):101.
142 Fugh-Berman A. Herb-drug interactions. Lancet 2000;355(9198):134.
143 Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002;27(6):391.
144 Ernst E. Possible interactions between synthetic and herbal medicinal products. Pt 1: A systematic review of the indirect evidence. Perfusion 2000;13:4.
145 Ernst E. Interactions between synthetic and herbal medicinal products. Pt 2: A systematic review of the direct evidence. Perfusion 2000;13:60.
146 Piscitelli SC, Burstein AH. Herb-drug interactions and confounding in clinical trials. J Herb Pharmacother 2002;2(1):23.
147 Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61(15):2163.
148 Hardy ML. Herb-drug interactions: An evidence-based table. Alt Med Alert 2000;June:64.
149 Lambrecht J, Hamilton W, Rabinovich A. A review of herb-drug interactions: documented and theoretical. US Pharmacist 2000;25(8):1.
150 Mathijssen RHJ, Verweij J, De Bruijn P, et al. Modulation of irinotecan (CPT-11) metabolism by St. John's wort in cancer patients. American Association for Cancer Research, 93rd Annual Meeting, San Francisco, April 6–10, 2002.
151 National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/.
152 Seifried HE, McDonald SS, Anderson DE, et al. The antioxidant conundrum in cancer. Cancer Res 2003;63:4295.
153 Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002; 137(11):889.
154 Burstein HJ, Gelber S, Guadagnoli E, at al. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340(22):1733. PubMed
155 DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002;20(18s):34s.
156 Dietary Supplement Health and Education Act of 1994 (DSHEA), Public Law 103-417, October 25, 1994 (103rd Congress).
157 Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997;127:61.
| < Anterior |
|---|
